title: Preeclampsia in autologous and oocyte donation pregnancy: is there a different pathophysiology?
abstract: Oocyte donation (OD) is a specific method of artificial reproductive technology that is accompanied by a higher risk of preeclampsia during pregnancy. The pathophysiological mechanism underlying preeclampsia in OD pregnancies is thought to differ from preeclampsia in autologous pregnancies. As preeclampsia in autologous pregnancies is suggested to be associated with complement activation, we studied C4d deposition, circulating complement components and placental complement regulatory proteins in preeclamptic OD pregnancies. Women with uncomplicated and preeclamptic pregnancies after OD or spontaneous conception were selected. We stained the placentas for C4d, marker for complement activation, measured complement factors C1q, C3 and C4 in maternal sera and quantified the placental mRNA expression of complement regulatory proteins CD46, CD55 and CD59. A significantly (p < 0.03) higher incidence of C4d deposition was observed in placentas from women with preeclampsia compared with uncomplicated pregnancies, both OD and autologous. The level of complement factors in serum did not differ between the groups. Children born in the autologous preeclampsia group were significantly lower in birth weight (p < 10th percentile) compared with the preeclamptic OD group. In addition, the placental mRNA expression level of complement regulatory proteins was significantly lower in uncomplicated and preeclamptic OD compared with the autologous pregnancies. In line with autologous preeclampsia pregnancies, there is excessive activation of complement in preeclamptic OD pregnancies. However, in contrast to autologous pregnancies this is not associated with counterbalancing upregulation of complement regulatory proteins. Furthermore, C4d deposition in OD pregnancies is not related to the severity of preeclampsia, suggesting another trigger or regulatory mechanism of placental C4d deposition in preeclamptic OD pregnancies.
authors: Department of Gynecology and Obstetrics, Leiden University Medical Centre, The Netherlands. Electronic address: e.e.l.o.lashley@lumc.nl.
authors: Lisa E E L O
authors: LE
authors: Lashley
authors: Department of Pathology, Leiden University Medical Centre, The Netherlands.
authors: Aletta
authors: A
authors: Buurma
authors: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, The Netherlands.
authors: Godelieve M J S
authors: GM
authors: Swings
authors: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, The Netherlands.
authors: Michael
authors: M
authors: Eikmans
authors: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, The Netherlands.
authors: Jacqueline D H
authors: JD
authors: Anholts
authors: Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Centre, The Netherlands.
authors: Jaap A
authors: JA
authors: Bakker
authors: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, The Netherlands.
authors: Frans H J
authors: FH
authors: Claas
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D003165:Complement System Proteins / Q000378:metabolism*; D005260:Female; D006801:Humans; D018587:Oocyte Donation; D010920:Placenta / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology*; D011225:Pre-Eclampsia / Q000097:blood* / Q000473:pathology / Q000503:physiopathology*; D011247:Pregnancy
chemical_list: D015415:Biomarkers; D003165:Complement System Proteins
keywords: C4d; Complement activation; Complement regulatory proteins; Oocyte donation; Placenta; Preeclampsia